Sean Laaman

Stock Analyst at Morgan Stanley

(2.64)

# 2,054

Out of 4,855 analysts

2

Total ratings

50%

Success rate

39.48%

Average return

Main Sectors:

Top Industries:

Biotechnology Medical Instruments & Supplies

Stocks Rated by Sean Laaman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALEC Alector	Assumes: Underweight	$3 → $1.5	$1.49	+1.01%	1	Mar 7, 2025
	RMD ResMed	Upgrades: Overweight	$169	$252.20	-32.99%	1	Oct 27, 2023

Alector

Mar 7, 2025

Assumes: Underweight

Price Target: $3 → $1.5

Current: $1.49

Upside: +1.01%

ResMed

Oct 27, 2023

Upgrades: Overweight

Price Target: $169

Current: $252.20

Upside: -32.99%